These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19833833)

  • 1. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
    Huestis MA
    Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.
    Badawi N; Simonsen KW; Steentoft A; Bernhoft IM; Linnet K
    Clin Chem; 2009 Nov; 55(11):2004-18. PubMed ID: 19797719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
    Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
    J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of 75 abuse drugs including amphetamines, benzodiazepines, cocaine, opioids, piperazines, zolpidem and metabolites in human hair samples using liquid chromatography-tandem mass spectrometry.
    Shin Y; Kong TY; Cheong JC; Kim JY; Lee JI; Lee HS
    Biomed Chromatogr; 2019 Sep; 33(9):e4600. PubMed ID: 31116452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
    Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
    Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
    Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
    Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS.
    Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T
    Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of the diagnostic yield of newborn drug testing.
    Wood KE; Sinclair LL; Rysgaard CD; Strathmann FG; McMillin GA; Krasowski MD
    BMC Pregnancy Childbirth; 2014 Jul; 14():250. PubMed ID: 25073780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QuEChERS sample preparation prior to LC-MS/MS determination of opiates, amphetamines, and cocaine metabolites in whole blood.
    Dulaurent S; El Balkhi S; Poncelet L; Gaulier JM; Marquet P; Saint-Marcoux F
    Anal Bioanal Chem; 2016 Feb; 408(5):1467-74. PubMed ID: 26753977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography.
    Schaefer N; Peters B; Schmidt P; Ewald AH
    Anal Bioanal Chem; 2013 Jan; 405(1):247-58. PubMed ID: 23076398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous detection and quantification of amphetamines, diazepam and its metabolites, cocaine and its metabolites, and opiates in hair by LC-ESI-MS-MS using a single extraction method.
    Miller EI; Wylie FM; Oliver JS
    J Anal Toxicol; 2008 Sep; 32(7):457-69. PubMed ID: 18713513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012-2017).
    Larabi IA; Fabresse N; Etting I; Nadour L; Pfau G; Raphalen JH; Philippe P; Edel Y; Alvarez JC
    Drug Alcohol Depend; 2019 Nov; 204():107508. PubMed ID: 31670189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
    Truver MT; Palmquist KB; Swortwood MJ
    J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
    Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral fluid contamination on two oral fluid testing systems.
    Reichardt EM; Baldwin D; Osselton MD
    J Anal Toxicol; 2013 May; 37(4):246-9. PubMed ID: 23471957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.
    Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ
    J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
    Röhrich J; Zörntlein S; Becker J; Urban R
    J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating community drug abuse by wastewater analysis.
    Zuccato E; Chiabrando C; Castiglioni S; Bagnati R; Fanelli R
    Environ Health Perspect; 2008 Aug; 116(8):1027-32. PubMed ID: 18709161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry.
    Reinstadler V; Lierheimer S; Boettcher M; Oberacher H
    Anal Bioanal Chem; 2019 Feb; 411(4):867-876. PubMed ID: 30519959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.